Counsel to Verlinvest in the tax aspects of its acquisition of a stake in Cible Skin
9.february.2024

Moncey Avocats advised Verlinvest on its acquisition of a stake in Cible Skin.
Cible Skin is an anti-aging dermatology center, a manufacturer of immuno-cosmetics and a pioneer in cellular rejuvenation research. It offers products that are 100% Clean and Made in France, and is recommended by leading international publications (Forbes, Vogue, Vanity Fair...). Cible Skin also produces a range of around ten products dedicated to skin care (serum, mask, cure, lotion, make-up remover, cream).
Verlinvest's investment will enable Cible Skin to accelerate its development in Europe.
Verlinvest was advised on tax matters by a team from Moncey Avocats comprising Frédéric Bosc, partner, and Manon Vanbiervliet, associate, as well as by Dentons on corporate aspects.